Actively Recruiting
Effects of a Nursing-led Communication Support Program Using Mobile Health Information on Physical and Mental Status in Breast Cancer Patients Undergoing Concurrent Chemotherapy: a Randomized Controlled Trial
Led by National Defense Medical Center, Taiwan · Updated on 2025-04-29
60
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Breast cancer is the most common malignant tumor among women, and chemotherapy can cause side effects such as sleep problems, anxiety, depression, and lower quality of life. Mental health challenges are a significant concern in cancer care. This research aims to study the effects of a nursing-led communication support program using mobile health information to help improve both physical and mental health in women undergoing initial chemotherapy for breast cancer. Participants will be randomly assigned to one of two groups: one group will receive a nursing-led communication support program that uses mobile health information, while the other group will receive routine nursing treatment. The study is designed as a randomized controlled trial with double masking to evaluate the impact of the communication program during chemotherapy treatment. During the study, researchers will monitor physical and mental health outcomes over the course of one year. Participants' progress will be assessed through various evaluations to understand the program's effects on their wellbeing. The study includes regular follow-up and safety monitoring to support participants throughout their chemotherapy treatment and beyond.
CONDITIONS
Brief Title
Effects of a Nursing-led Communication Using Mobile Health Information in Breast Cancer Patients Undergoing Concurrent Chemotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients undergoing initial chemotherapy for breast cancer
- Age 18 years or older
You will not qualify if you...
- Patients whose cancer has recurred without undergoing the first course of chemotherapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of initial chemotherapy
Participants undergo initial chemotherapy for breast cancer while receiving either nursing-led communication support using mobile health information or nursing routine treatment.
Visits according to chemotherapy schedule
Duration - Up to 1 year
Participants are monitored for effects on physical and mental status related to the nursing-led communication support program during and after chemotherapy.
Periodic visits for up to 1 year
Trial Site Locations
Total: 1 location
1
Tri-Service General Hospital
Taipei, Taiwan
Actively Recruiting
Research Team
M
Man Mei Postdoctoral researcher
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here